Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

OPKO Health Q2 2024 GAAP EPS $(0.01) Beats $(0.09) Estimate, Sales $182.200M Miss $185.190M Estimate

Author: Benzinga Newsdesk | August 07, 2024 05:06pm
OPKO Health (NASDAQ:OPK) reported quarterly losses of $(0.01) per share which beat the analyst consensus estimate of $(0.09) by 88.89 percent. The company reported quarterly sales of $182.200 million which missed the analyst consensus estimate of $185.190 million by 1.61 percent. This is a 31.35 percent decrease over sales of $265.400 million the same period last year.

Posted In: OPK


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist